Pampee Young

December 17, 2021

Family knows firsthand the critical need for blood donations

Vanderbilt cancer patient Brody Cramer knows all too well how crucial blood donations are. Since he was diagnosed with leukemia earlier this year he has needed 23 units of red blood cells and 16 units of platelets.

By Jessica Pasley
Pampee Young, MD, PhD, left, Sarika Saraswati, PhD, and colleagues are studying the different ways fibroblasts function following tissue injury.
August 8, 2019

Cellular engines of wound repair have distinct roles

Vanderbilt investigators have discovered that, in contrast to prevailing dogma, fibroblasts are not all alike; instead, they have distinctive functions following tissue injury.

By Leigh MacMillan
January 4, 2018

Young named chief medical officer of American Red Cross

Vanderbilt’s Pampee Young, MD, PhD, has been named chief medical officer of the American Red Cross.

By Tom Wilemon
April 28, 2016

Surgical training enhances VUMC, Fort Campbell bond

During a deployment as a military surgeon more than a decade ago, Vanderbilt University Medical Center’s Tim Nunez, M.D., felt ill prepared to perform complex trauma surgeries for an Iraqi family caught in a fire fight, but he’s now committed to helping military personnel become better trained for these types of emergencies.

By Jill Clendening
October 16, 2015

Healing without scarring

Drugs that inhibit the Wnt signaling pathway can regenerate injured skin and may be useful in treating fibromatosis, degenerative joint disease and cancer.

By Sanjay Mishra
May 15, 2015

Boosting cell-based heart repair

A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells.

By Leigh MacMillan
May 4, 2015

Kids more likely to react to blood transfusions

Pediatric patients have a significantly higher incidence of transfusion reactions compared to adults, according to a study by Vanderbilt University researchers.
By Bill Snyder
December 17, 2014

Target for atherosclerosis therapies

A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.
By Leigh MacMillan
June 10, 2013

Factor’s yin-yang tumor effects

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.
By Leigh MacMillan
May 17, 2012

Long live the therapeutic stem cells

Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
By Leigh MacMillan